Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management

The Journal of Urology
Fanny SampurnoSue M Evans

Abstract

We sought to develop a core set of clinical indicators to enable international benchmarking of localized prostate cancer management using data available in the TrueNTH Global Registry. An international expert panel completed an online survey and participated in a face-to-face meeting. Participants included 3 urologists, 3 radiation oncologists, 2 psychologists, 1 medical oncologist, 1 nurse and 1 epidemiologist with prostate cancer expertise from a total of 7 countries. Current guidelines on prostate cancer treatment and potential quality indicators were identified from a literature review. These potential indicators were refined and developed through a modified Delphi process during which each panelist independently and repeatedly rated each indicator based on importance (satisfying the indicator demonstrated a provision of high quality care) and feasibility (the likelihood that data used to construct the indicator could be collected at a population level). The main outcome measure was items with panel agreement indicated by a disagreement index less 1, median importance 8.5 or greater and median feasibility 9 or greater. The expert panel endorsed 33 indicators. Seven of these 33 prostate cancer quality indicators assessed car...Continue Reading

References

May 30, 2001·International Journal of Cardiology·M D AguilarS J Bernstein
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin A SpencerMark S Litwin
Mar 21, 2008·The New England Journal of Medicine·Martin G SandaJohn T Wei
Sep 27, 2008·The Journal of Urology·Richard J BabaianJ Brantley Thrasher
Mar 23, 2011·The Journal of Urology·Wesley W ChoiJim C Hu
Jul 16, 2013·Journal of the National Cancer Institute·Danil V MakarovPär Stattin
Oct 30, 2013·BJU International·James ThompsonUNKNOWN USANZ
Oct 23, 2013·The Journal of Urology·Florian R SchroeckBrent K Hollenbeck
Dec 11, 2013·International Journal of Radiation Oncology, Biology, Physics·Aaron D FalchookRonald C Chen
Sep 24, 2015·World Journal of Urology·Christoph KowalskiSimone Wesselmann
Dec 9, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan BaschDeborah Schrag
Apr 30, 2016·The Medical Journal of Australia·Fanny SampurnoSue M Evans
May 18, 2016·The Journal of Urology·Sam S Chang
Oct 22, 2016·JAMA Oncology·Stacy LoebPär Stattin

❮ Previous
Next ❯

Citations

Oct 24, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sophie D FossåTor A Myklebust
Jun 5, 2021·Health Informatics Journal·Fanny SampurnoSue M Evans

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Lara BestMichael Brundage
Journal of Child Neurology
C Jason WangLaurie Douglass
Journal of the National Comprehensive Cancer Network : JNCCN
Carlos CampsEduardo Díaz-Rubio
© 2022 Meta ULC. All rights reserved